Individual provider · Type 1 NPI
Michael Lapelusa, MD
Hematology & Oncology Physician · Kansas City, MO
Practice location
2316 E Meyer Blvd # 1E
Kansas City, MO 64132-1136
Fax (816) 683-7645
Mailing address
PO Box 749495
Atlanta, GA 30374-9495
Other practice locations
- 8919 Parallel Pkwy Ste 326W, Kansas City, KS 66112-1655 · (913) 804-4031
- 17053 S Outer Rd Fl 1, Belton, MO 64012-2165 · (816) 974-5050
- 2750 Clay Edwards Dr Lowr Level, Kansas City, MO 64116-3237 · (816) 691-2880
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Hematology & Oncology Physician Primary | 207RH0003X | 2026018403 (MO) |
Hematology & Oncology Physician: An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
Other hematology & oncology physician providers in Kansas City
- Kimberly Kay Pluenneke, MDHematology & Oncology Physician Kansas City, MO NPI 1013282664
- Jerilyn Hart, DOHematology & Oncology Physician Kansas City, MO NPI 1033312996
- Marci Rachel Allen, DOHematology & Oncology Physician Kansas City, MO NPI 1063672012
- Kerry Jean Williams-Wuch, MDHematology & Oncology Physician Kansas City, MO NPI 1073655585
- Jaswinder Singh, MDHematology & Oncology Physician Kansas City, MO NPI 1093747677
- Mark H. Dewolfe, MDHematology & Oncology Physician Kansas City, MO NPI 1124021142
- Karan Josan, MDHematology & Oncology Physician Kansas City, MO NPI 1124491717
- Zaheer Ahmed, MDHematology & Oncology Physician Kansas City, MO NPI 1205178456
About NPI 1831728401
Michael Lapelusa, MD's National Provider Identifier is 1831728401, issued on Apr 6, 2020. The primary taxonomy on file is Hematology & Oncology Physician (207RH0003X), and the practice location is in Kansas City, MO. The record was last updated on Sep 1, 2026.